|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | C12N 15/62 | (2006.01) |
| C07K 14/33 | (2006.01) | ||
| A61K 39/08 | (2006.01) |
| (11) | Number of the document | 3138916 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16193340.3 |
| Date of filing the European patent application | 2012-05-25 | |
| (97) | Date of publication of the European application | 2017-03-08 |
| (45) | Date of publication and mention of the grant of the patent | 2019-06-19 |
| (46) | Date of publication of the claims translation | 2019-08-26 |
| (30) | Number | Date | Country code |
| 201161490707 P | 2011-05-27 | US | |
| 201161490734 P | 2011-05-27 | US | |
| 201161490716 P | 2011-05-27 | US |
| (72) |
CASTADO, Cindy, BE
|
| (73) |
GlaxoSmithKline Biologicals S.A.,
Rue de l`Institut, 89, 1330 Rixensart,
BE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Imunogeninė kompozicija |
| IMMUNOGENIC COMPOSITION |
| Payment date | Validity (years) | Amount | |
| 2023-04-20 | 12 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2023-10-24 |